CHU de Quebec-Universite Laval-Hotel Dieu de Quebec

Québec, Quebec G1R 3S1

0 studies enrolling now · 3 studies all time

What they study most

Head and Neck Cancer, Renal Cell Carcinoma (RCC), UC (Urothelial Cancer)

Studies at this site

• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) — Completed
• Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma — Completed